- RDY has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $11.3 million.
- RDY has traded 3,758 shares today.
- RDY is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in RDY with the Ticky from Trade-Ideas. See the FREE profile for RDY NOW at Trade-Ideas More details on RDY: Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company in India. It operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The stock currently has a dividend yield of 0.5%. RDY has a PE ratio of 27.7. Currently there are no analysts that rate Dr Reddy Laboratories a buy, 1 analyst rates it a sell, and 1 rates it a hold. The average volume for Dr Reddy Laboratories has been 232,600 shares per day over the past 30 days. Dr Reddy has a market cap of $9.9 billion and is part of the health care sector and drugs industry. Shares are up 41.9% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.